Verimmune Competitors and Similar CompaniesClear all

Verimmune's competitors and similar companies include Lyell, Nkarta Therapeutics, Verismo Therapeutics and CARGO Therapeutics.

	Verimmune VerImmune is a biotechnology company specializing in cancer therapy.	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	Nkarta Therapeutics Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.	Verismo Therapeutics Verismo Therapeutics is a company that develops a KIR-CAR platform for cancer treatment.	CARGO Therapeutics CARGO Therapeutics (formerly known as Syncopation Life Sciences) is a company that develops a platform for cancer treatment.
Founding Date	Founding Date 2016	Founding Date 2018	Founding Date 2015	Founding Date 2020	Founding Date 2019
Type	Type Private	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech medical records oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology platform therapy
Locations	Locations Washington, US HQ	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations South San Francisco, US HQ	Locations Philadelphia, US HQ	Locations San Mateo, US HQ
Employees	Employees 137% decrease	Employees 188	Employees 1594% decrease	Employees 28	Employees 74
Valuation ($)	Valuation ($) N/A	Valuation ($) 243.3 m	Valuation ($) 240.6 m	Valuation ($) N/A	Valuation ($) 1 b
Financial
Net income	Net income N/A	Net income ($274.4m) (FY, 2025)	Net income ($104.1m) (FY, 2025)	Net income N/A	Net income ($167.5m) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 4.6m	Total funding raised N/A	Total funding raised $ 125m	Total funding raised N/A	Total funding raised N/A